Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

Determination of lamivudine-resistant variants of hepatitis B virus by denaturing gradient gel electrophoresis: A novel approach to monitoring drug resistance

In English

Författare

  • Krzysztof Plotr Bielawski
  • Waleed Abu Al-Soud
  • Plotr Stalke
  • Urszula Charmuszko
  • Torkel Wadström

Summary, in English

Background: A DGGE-based assay for hepatitis B virus (HBV) drug-resistance monitoring was designed and checked for feasibility. It detects mutations within the YMDD motif related to lamivudine resistance. Material/Methods: The YMDD motif of HBV polymerase was amplified by the set of primers designed in this study. DGGE analysis of the amplicons was performed on 9% polyacrylamide gels containing a 20-40% gradient of urea plus formamide and electrophoresis was performed. DNA sequencing was performed using a standard protocol. Results: Based on the DGGE pattern of previously sequenced HBV variants, a reference ladder consisting of bands was constructed within and near the YMDD motif of HBV with excellent resolution. The genotypes of all the fragments included in the ladder were confirmed by sequencing after DGGE analysis. The flexibility of DGGE was demonstrated by the ability to add more bands to the migration ladder when new variants were discovered during the analysis of patient specimens. Clinical samples from HBV-infected patients were also used to demonstrate the performance of this approach. Conclusions: This preliminary feasibility study of HBV drug-resistance monitoring by means of DGGE shows the potential advantage of this approach for low-cost screening for viral drug resistance in clinical settings. The presented example can be extended to detect other mutations related to drug resistance in the HBV genome as well as other viruses.

Publiceringsår

2008

Språk

Engelska

Sidor

281-285

Publikation/Tidskrift/Serie

Medical Science Monitor

Volym

14

Issue

5

Dokumenttyp

Artikel i tidskrift

Förlag

Medical Science Monitor

Ämne

  • Microbiology in the medical area

Nyckelord

  • genotyping
  • viral drug resistance
  • hepatitis B
  • YMDD motif mutation

Status

Published

ISBN/ISSN/Övrigt

  • ISSN: 1643-3750